References
- Backman H, Raisanen P, Hedman L, Stridsman C, Andersson M, Lindberg A, et al. Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016-results from three population surveys. Clinical and Experimental Allergy. 2017;47: 1426–1435.
- Badan Penelitian Pengembangan Kesehatan. Hasil Utama RISKESDAS 2018. 2018; Available from:
http://www.depkes.go.id/resources/download/info-terkini/hasil-riskesdas-2018.pdf [Accessed 12th August 2019]. - Wijesinghe M, Weatherall M, Perrin K, Crane J, Beasley R. International trends in asthma mortality rates in the 5- to 34-year age group: a call for closer surveillance. Chest. 2009;135: 1045–1049.
- Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. Journal of Allergy and Clinical Immunology. 2001;107:937–944.
- Szefler SJ. Advancing asthma care: the glass is only half full! Journal of Allergy Clinical Immunology. 2011;128: 485–494.
- Levy ML, Andrews R, Buckingham R, Evans H, Francis C, Houston R, et al. Why asthma still kills: The National Review of Asthma Deaths (NRAD); 2014.
- Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Primary Care Respiratory Medicine. 2014;24: 14009.
- Nathan RA, Thompson PJ, Price D, Fabbri LM, Salvi S, González-Díaz S, et al. Taking aim at asthma around the world: global results of the asthma insight and management survey in the Asia-Pacific region, Latin America, Europe, Canada, and the United States. The Journal of Allergy and Clinical Immunology: In Practice. 2015;3: 734–742 e735.
- Inman WH, Adelstein AM. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet. 1969;2: 279–285.
- Stolley PD. Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma. The American Review of Respiratory Disease. 1972;105: 883–890.
- Beasley R. A historical perspective of the New Zealand asthma mortality epidemics. The Journal of Allergy and Clinical Immunology. 2006;117: 225–228.
- Jackson RT, Beaglehole R, Rea HH, Sutherland DC. Mortality from asthma: a new epidemic in New Zealand. British Medical Journal (Clinical Research Ed). 1982;285: 771–774.
- Lanes SF, Birmann B, Raiford D, Walker AM. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970–1992. Journal of Clinical Epidemiology. 1997;50: 321–328.
- Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981–83: case-control study. Lancet. 1989;1: 917–922.
- Crane J, Pearce N, Burgess C, Jackson R, Beasley R. End of New Zealand asthma epidemic. Lancet. 1995;345: 984–985.
- Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma. The New England Journal of Medicine. 1992;326: 501–506.
- Garrett JE, Lanes SF, Kolbe J, Rea HH. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity. Thorax. 1996;51: 1093–1099.
- Beasley R, Pearce N, Crane J, Burgess C. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic. International Archives of Allergy and Immunology. 1995;107: 325–327.
- Ebmeier S, Thayabaran D, Braithwaite I, Bénamara C, Weatherall M, Beasley R. Trends in international asthma mortality: analysis of data from the WHO mortality database from 46 countries (1993–2012). Lancet. 2017;390: 935–945.
- Ito Y, Tamakoshi A, Wakai K, Takagi K, Yamaki K, Ohno Y. Trends in asthma mortality in Japan. Journal of Asthma. 2002;39: 633–639.
- Statistics and Information Department MsS, Ministry of Health and Welfare, Japan. Vital Statistics Japan; 2019.
- D’Amato G, Vitale C, Molino A, Stanziola A, Sanduzzi A, Vatrella A, et al. Asthma-related deaths. Multidisciplinary Respiratory Medicine. 2016;11: 37.
- Perhimpunan Dokter Paru Indonesia (PDPI). Asma Pedoman Diagnosis dan Penatalaksaan di Indonesia. Perhimpunan Dokter Paru Indonesia; 2018.
- D’Amato G, Annesi Maesano I, Molino A, Vitale C, D’Amato M Thunderstorm-related asthma attacks. The Journal of Allergy and Clinical Immunology. 2017;139: 1786–1787.
- Ali F, Behbehani N, Alomair N, Taher A. Fatal and near-fatal thunderstorm asthma epidemic in a desert country. Annals of Thoracic Medicine. 2019;14: 155–160.
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention 2019. Available from:
www.ginaasthma.org . [Accessed 12th August 2019]. - Liu Y, Pan J, Zhang H, Shi C, Li G, Peng Z, et al. Short-term exposure to ambient air pollution and asthma mortality. American Journal of Respiratory and Critical Care Medicine. 2019;200: 24–32.
- D’Amato G, Vitale C, Lanza M, et al. Near fatal asthma: treatment and prevention. European Annals of Allergy and Clinical Immunology. 2016;48: 116–122.
- Richards GN, Kolbe J, Fenwick J, Rea HH. Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths. Thorax. 1993;48: 1105–1109.
- Alvarez GG, Schulzer M, Jung D, Fitzgerald JM. A systematic review of risk factors associated with near-fatal and fatal asthma. Canadian Respiratory Journal. 2005;12: 265–270.
- Suissa S, Blais L, Ernst P. Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. European Respiratory Journal. 1994;7: 1602–1609.
- Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RF Jr, Sorkness CA, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA. 2001;285: 2583–2593.
- Barnes PJ. Beta-adrenergic receptors and their regulation. American Journal of Respiratory and Critical Care Medicine. 1995;152: 838–860.
- Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. New England Journal of Medicine. 2001;345: 1030–1035.
- Haney S, Hancox RJ. Rapid onset of tolerance to beta-agonist bronchodilation. Respiratory Medicine. 2005;99: 566–571.
- Haney S, Hancox RJ. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial. Respiratory Research. 2005;6: 107.
- Wraight JM, Hancox RJ, Herbison GP, Cowan JO, Flannery EM, Taylor DR. Bronchodilator tolerance: the impact of increasing bronchoconstriction. The European Respiratory Journal. 2003;21: 810–815.
- Gauvreau GM, Jordana M, Watson RM, Cockroft DW, O’Byrne PM. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. American Journal of Respiratory and Critical Care Medicine. 1997;156: 1738–1745.
- O’Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? European Respiratory Journal. 2017;50(3): pii:1701103.
- Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest. 2004;125: 2309–2321.
- Bremner P, Siebers R, Crane J, Beasley R, Burgess C. Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol. Chest. 1996;109: 957–962.
- Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet. 1990;336: 1396–1399.
- Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockroft D, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. American Journal of Respiratory and Critical Care Medicine. 1994;149: 604–610.
- Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. The New England Journal of Medicine. 2000;343: 332–336.
- Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group. The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129: 15–26.
- Weatherall M, Wijesinghe M, Perrin K, Harwood M, Beasley R. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax. 2010;65: 39–43.
- Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. European Respiratory Journal. 2002;19: 182–191.
- Burks AW, Tang M, Sicherer S, Muraro A, Eigenmann PA, Ebisawa M, et al. ICON: food allergy. The Journal of Allergy and Clinical Immunology. 2012;129: 906–920.
- Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001–2006. The Journal of Allergy and Clinical Immunology. 2007;119: 1016–1018.
- Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999–2006. The Journal of Allergy and Clinical Immunology. 2007;119: 1018–1019.
- Air Quality Index Jakarta Air Pollution: Real-time Air Quality Index (AQI). Available from:
http://www.aqicn.info/city/jakarta . [Accessed 12th August 2019]. - Air Now. Air Quality Index (AQI) Basics. Available from:
https://airnow.gov/index.cfm?action=aqibasics.aqi . [Accessed 12th August 2019]. - Guarnieri M, Balmes JR. Outdoor air pollution and asthma. Lancet. 2014;383: 1581–1592.
- Kravchenko J, Akushevich I, Abernethy AP, Holman S, Ross WG Jr, Lyerly HK. Long-term dynamics of death rates of emphysema, asthma, and pneumonia and improving air quality. International Journal of Chronic Obstructive Pulmonary Disease. 2014;9: 613–627.